What is the share price of Health X Platform Ltd (HEALTHX) today?
The share price of HEALTHX as on 21st September 2026 is ₹297. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Health X Platform Ltd (HEALTHX) share?
The past returns of Health X Platform Ltd (HEALTHX) share are- Past 1 week: -1.33%
- Past 1 month: -2.62%
- Past 3 months: -6.07%
- Past 6 months: 7.18%
- Past 1 year: -9.52%
- Past 3 years: 8.43%
- Past 5 years: -0.20%
What are the peers or stocks similar to Health X Platform Ltd (HEALTHX)?
The peers or stocks similar to Health X Platform Ltd (HEALTHX) include:What is the market cap of Health X Platform Ltd (HEALTHX) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Health X Platform Ltd (HEALTHX) is ₹954.32 Cr as of 21st September 2026.What is the 52 week high and low of Health X Platform Ltd (HEALTHX) share?
The 52-week high of Health X Platform Ltd (HEALTHX) is ₹363 and the 52-week low is ₹252.50.What is the PE and PB ratio of Health X Platform Ltd (HEALTHX) stock?
The P/E (price-to-earnings) ratio of Health X Platform Ltd (HEALTHX) is 808.74. The P/B (price-to-book) ratio is 1.10.Which sector does Health X Platform Ltd (HEALTHX) belong to?
Health X Platform Ltd (HEALTHX) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Health X Platform Ltd (HEALTHX) shares?
You can directly buy Health X Platform Ltd (HEALTHX) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Health X Platform Ltd
HEALTHX Share Price
NSE₹297.001.00% (-3.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
HEALTHX Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
HEALTHX Performance & Key Metrics
HEALTHX Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -47.20 | 1.10 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
HEALTHX Company Profile
Health X Platform Limited operates digital healthcare networks offering pharmacy, diagnostics, wellness products, pathology, radiology, and financial services including loans, wealth management, and financial consultancy in India.
PE Ratio
41.38
41.38
1Y Return
18.86%
18.86%
Buy Reco %
77.78
77.78
POLYMED
PE Ratio
54.31
54.31
1Y Return
12.18%
12.18%
Buy Reco %
80.00
80.00
PE Ratio
89.11
89.11
1Y Return
17.21%
17.21%
TARSONS
PE Ratio
113.81
113.81
1Y Return
11.83%
11.83%
Buy Reco %
100.00
100.00
LAXMIDENTL
PE Ratio
37.58
37.58
1Y Return
42.37%
42.37%
Buy Reco %
100.00
100.00
HEALTHX Sentiment Analysis
HEALTHX Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
HEALTHX Stock Summary · August 2026
Management’s message on the call was one of clear recovery and continued platform building, with strong growth now starting to translate into better profitability. Q1 FY27 revenue rose 58% year on year and 16% sequentially to INR440 crores, while gross profit and margin improved and PAT turned positive at INR2 crores from a INR13 crores loss in Q4 FY26, despite higher employee and operating expenses. Management said this reflected improving operational leverage, helped by broad-based momentum at RetailerShakti and SastaSundar, where revenues grew 48% and 44% respectively. They emphasized a capital-efficient, technology-led healthcare model supported by tightly managed working capital at about 28 days, contribution-margin-positive revenue, direct sourcing for over 95% of purchases, and purchase returns below 1%. Growth beyond West Bengal, with about 30% of business now coming from outside the state, and private-label JITO were presented as additional levers, though management also noted that SastaSundar remains a long-term investment business. Near term, they said RetailerShakti is close to EBITDA break-even and should turn positive in Q3, while SastaSundar is not expected to be EBITDA positive for two to three years.
HEALTHX Stock Growth Drivers
HEALTHX Stock Growth Drivers
10Revenue Momentum from Core Platforms and Prior Investments
The company is seeing clear operating momentum as prior investments in platforms, geography, fulfillment, technology,
Capital-Efficient Model with Strong Operating Economics
A recurring strength is the company’s capital-efficient structure, which management believes can support growth without
HEALTHX Stock Challenges
HEALTHX Stock Challenges
4Persistent Cost Pressure and Weak Operating Profitability
The company continues to face pressure on operating profitability from higher employee and other operating
Prolonged Loss-Making Phase in the B2C Platform Build-Out
The SastaSundar/Health Buddy business is being developed through heavy upfront technology and revenue-building investment, and
HEALTHX Forecast
HEALTHX Forecasts
Price
Revenue
Earnings
HEALTHX Share Price Forecast
HEALTHX Share Price Forecast
2026
Current
₹297.00
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹297.00
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HEALTHX Company Revenue Forecast
HEALTHX Company Revenue Forecast
2026
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
HEALTHX Stock EPS (Earnings Per Share) Forecast
HEALTHX Stock EPS (Earnings Per Share) Forecast
2026
Current
₹0.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹0.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HEALTHX
HEALTHX
Income
Balance Sheet
Cash Flow
Quarterly Normal View
HEALTHX Income Statement
HEALTHX Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 325.13 | 299.04 | 295.82 | 269.46 | 307.75 | 323.81 | 306.83 | 359.35 | 387.54 | 459.68 | ||||||||||
Operating & Other expenses | 317.59 | 272.80 | 468.01 | 307.26 | 311.03 | 292.46 | 324.15 | 356.27 | 400.43 | 455.81 | ||||||||||
EBITDA | 7.54 | 26.24 | -172.19 | -37.80 | -3.28 | 31.35 | -17.32 | 3.08 | -12.89 | 3.87 | ||||||||||
| Depreciation/Amortization | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 | 1.94 | 1.89 | ||||||||||
| PBIT | 5.01 | 24.63 | -173.64 | -39.23 | -4.62 | 30.18 | -18.65 | 0.91 | -14.83 | 1.98 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | 5.01 | 24.63 | -173.64 | -39.23 | -4.62 | 30.18 | -18.65 | 0.91 | -14.83 | 1.98 | ||||||||||
| Taxes & Other Items | -11.41 | -6.52 | -64.21 | -12.31 | -18.30 | 6.27 | -5.95 | -0.21 | -3.65 | -0.56 | ||||||||||
| Net Income | 16.42 | 31.15 | -109.43 | -26.92 | 13.68 | 23.91 | -12.70 | 1.12 | -11.18 | 2.54 | ||||||||||
| EPS | 5.17 | 9.79 | -34.40 | -8.47 | 4.30 | 7.52 | -3.99 | 0.35 | -3.51 | 0.80 |
HEALTHX Company Updates
FY 2027FY 2027
Investor Presentation
Aug 7PDF
HEALTHX Stock Peers
HEALTHX Past Performance & Peer Comparison
HEALTHX Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Health X Platform Ltd | 808.74 | 1.10 | — |
| Inventurus Knowledge Solutions Ltd | 41.38 | 10.66 | — |
| Poly Medicure Limited | 54.31 | 5.56 | 0.20% |
| Molbio Diagnostics Limited | 89.11 | 11.34 | — |
HEALTHX Stock Price Comparison
Compare HEALTHX with any stock or ETFCompare HEALTHX with any stock or ETF
HEALTHX
HEALTHX Holdings
HEALTHX Shareholdings
HEALTHX Promoter Holdings Trend
HEALTHX Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
HEALTHX Institutional Holdings Trend
HEALTHX Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
HEALTHX Shareholding Pattern
HEALTHX Shareholding Pattern
HEALTHX Shareholding History
HEALTHX Shareholding History
Foreign Institutions
Mutual Funds Invested in HEALTHX
Mutual Funds Invested in HEALTHX
No mutual funds holding trends are available
Top 1 Mutual Funds holding Health X Platform Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0003% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 124/130 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing HEALTHX stock
smallcases containing HEALTHX stock
Looks like this stock is not in any smallcase yet.
HEALTHX Events
HEALTHX Events
HEALTHX Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HEALTHX has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
HEALTHX Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HEALTHX has not given any dividends in last 5 years
HEALTHX Upcoming Dividends
HEALTHX Upcoming Dividends
No upcoming dividends are available
HEALTHX Past Dividends
HEALTHX Past Dividends
Cash Dividend
Ex DateEx DateJul 23, 2012
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 23, 2012
Cash Dividend
Ex DateEx DateJul 25, 2011
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 25, 2011
HEALTHX Stock News & Opinions
HEALTHX Stock News & Opinions
Articles & Videos
Earnings
Earnings
Health X Platform Ltd consolidated sales up 19.55% on year in Q2FY2026Health X Platform Ltd share price inched up 2.07% to Rs 313.55 after the company's net profit tanked by 115.34% to Rs 1.99 crore, while revenue from operations edged up 19.55% to Rs 446.85 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 73444.53 crore, rising 9.78%. It has improved by 0.70% over last one week and moving up by 12.28% in last one month while the market capitalization of Health X Platform Ltd has marginally improved by 0.50% and 5.31% in the same period respectively. Profit before tax (PBT) of Health X Platform Ltd stood at Rs 1.97 crore in Q2 FY26, nosediving by 93.47% year-on-year, and crashing by 113.28% quarter-on-quarter. EBITDA came in at Rs 22 crore, advancing by 12.31% YoY and tanking 44.73% sequentially. Total expenses increased by 14.03% to Rs 457.7 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 0.17 crore, surging by 70% YoY, while employee benefits expense was at Rs 27.68 crore, registering a growth of 10.54% YoY. For the TTM ended FY26, revenue from operations declined by 19.25% to Rs 1110.95 crore, while net profit plunged by 233.37% to Rs 122.74 crore, compared to previous TTM. EBITDA saw a sharp decline of 6031% to Rs 116.08 crore, and PBT collapsed by 446.37% to Rs 192.86 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 17.31 crore in FY26, as against Rs 35.86 crore in FY25. Health X Platform Ltd soared by 16.50% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 1.97% during the same period.
1 month agoCapital Market - Live
Earnings
Earnings
Health X Platform reports consolidated net loss of Rs 11.17 crore in the March 2026 quarterNet loss of Health X Platform reported to Rs 11.17 crore in the quarter ended March 2026 as against net profit of Rs 13.67 crore during the previous quarter ended March 2025. Sales rose 30.77% to Rs 373.78 crore in the quarter ended March 2026 as against Rs 285.84 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 1.18 crore in the year ended March 2026 as against net loss of Rs 91.17 crore during the previous year ended March 2025. Sales rose 18.75% to Rs 1319.27 crore in the year ended March 2026 as against Rs 1110.95 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales373.78285.84 31 1319.271110.95 19 OPM %-6.74-8.81 --3.95-5.04 - PBDT-11.92-3.58 -233 5.383.60 49 PBT-13.87-4.91 -182 -1.23-2.23 45 NP-11.1713.67 PL 1.18-91.17 LP Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Health X Platform to discuss resultsHealth X Platform will hold a meeting of the Board of Directors of the Company on 30 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Sastasundar Ventures reports consolidated net profit of Rs 1.13 crore in the December 2025 quarterNet profit of Sastasundar Ventures reported to Rs 1.13 crore in the quarter ended December 2025 as against net loss of Rs 26.94 crore during the previous quarter ended December 2024. Sales rose 22.91% to Rs 345.74 crore in the quarter ended December 2025 as against Rs 281.29 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales345.74281.29 23 OPM %-3.00-8.43 - PBDT3.09-35.58 LP PBT0.92-37.01 LP NP1.13-26.94 LP Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Sastasundar Ventures announces board meeting dateSastasundar Ventures will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Sastasundar Ventures reports consolidated net loss of Rs 12.69 crore in the September 2025 quarterNet Loss of Sastasundar Ventures reported to Rs 12.69 crore in the quarter ended September 2025 as against net loss of Rs 109.41 crore during the previous quarter ended September 2024. Sales rose 10.16% to Rs 301.32 crore in the quarter ended September 2025 as against Rs 273.53 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales301.32273.53 10 OPM %-7.50-1.73 - PBDT-17.1417.51 PL PBT-18.4716.05 PL NP-12.69-109.41 88 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Sastasundar Ventures to conduct board meetingSastasundar Ventures will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Sastasundar Ventures to convene AGMSastasundar Ventures announced that the 36th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Earnings
Earnings
Sastasundar Ventures consolidated net profit declines 23.24% in the June 2025 quarterNet profit of Sastasundar Ventures declined 23.24% to Rs 23.91 crore in the quarter ended June 2025 as against Rs 31.15 crore during the previous quarter ended June 2024. Sales rose 10.41% to Rs 298.43 crore in the quarter ended June 2025 as against Rs 270.29 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales298.43270.29 10 OPM %2.03-0.89 - PBDT31.3525.25 24 PBT30.1923.64 28 NP23.9131.15 -23 Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Sastasundar Ventures to hold board meetingSastasundar Ventures will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 20.09%, vs industry avg of 18.08%
Over the last 5 years, market share decreased from 13.37% to 12.38%